These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1023973)

  • 21. Rational use of antiarrhythmic drugs alone and in combination.
    Bigger JT; Giardina EG
    Cardiovasc Clin; 1974; 6(2):103-17. PubMed ID: 4613454
    [No Abstract]   [Full Text] [Related]  

  • 22. Antiarrhythmic activity of the hydrochloride of 1-methoxymethyl-2-(1-perhydroazepinyl)ethyl ester of 2-(n)-pentyloxycarbanilic acid.
    Gibala P; Sotníková R; Knezl V; Drímal J
    Arzneimittelforschung; 1987 Feb; 37(2):149-52. PubMed ID: 3580018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Classification and pharmacology of antiarrhythmic drugs.
    Kowey PR; Marinchak RA; Rials SJ; Bharucha DB
    Am Heart J; 2000 Jul; 140(1):12-20. PubMed ID: 10874257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental evaluation of antiarrhythmic drugs efficacy.
    Schwartz PJ; Vanoli E; Zaza A; Zuanetti G
    Cardiologia; 1983 Sep; 28(9):747-65. PubMed ID: 6687331
    [No Abstract]   [Full Text] [Related]  

  • 25. [The cardiotoxic properties of anti-arrhythmia agents].
    Spasov AA; Gurova NA
    Eksp Klin Farmakol; 1997; 60(2):20-3. PubMed ID: 9206561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antiarrhythmic properties of fubromegan on different models of experimental cardiac arrhythmia].
    Samvelian VM; L'vov MV
    Farmakol Toksikol; 1970; 33(3):309-13. PubMed ID: 4393833
    [No Abstract]   [Full Text] [Related]  

  • 27. Arrhythmias and antiarrhythmic drugs.
    Bigger JT
    Adv Intern Med; 1972; 18():251-81. PubMed ID: 4576083
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical pharmacology of antiarrhythmic drugs: variability of metabolism and dose requirements.
    Follath F
    J Cardiovasc Pharmacol; 1991; 17 Suppl 6():S74-6. PubMed ID: 1723123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anti-arrhythmia properties of pyromecaine].
    Zakusov VV; Prianishnikova NT; Cherniakova IV; Samvelian VM; L'vov MV
    Farmakol Toksikol; 1983; 46(5):32-7. PubMed ID: 6628657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of the anti-arrhythmia and local anesthetizing actions of some substances].
    Diadiura ZhA; L'vov MV
    Farmakol Toksikol; 1975; 38(2):170-3. PubMed ID: 1227882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antiarrhythmic action of certain 1,5-diphenyl-bispidin derivatives].
    Cartoni C; Figini A; Carpi A
    Ann Ist Super Sanita; 1968; 4(3):333-5. PubMed ID: 5734619
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparative effectiveness of the beta-(N,N-diethylamino)ethylamide hydrochloride of fusaric acid, obzidan and atenolol in experimental adrenaline-induced cardiac arrhythmia].
    Savina MD
    Farmakol Toksikol; 1986; 49(3):47-50. PubMed ID: 3720934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-arrhythmic activity of trimecaine under experimental and clinical conditions].
    Samvelian VM; Prianishnikova NT; Pogosian SA; Vasilian SS; Markarian KZh; Diadiura ZhA
    Kardiologiia; 1978 Apr; 18(4):85-9. PubMed ID: 671974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological modulation of cardiac gap junctions to enhance cardiac conduction: evidence supporting a novel target for antiarrhythmic therapy.
    Eloff BC; Gilat E; Wan X; Rosenbaum DS
    Circulation; 2003 Dec; 108(25):3157-63. PubMed ID: 14656916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antiarrhythmic activity of trimecaine in experimental arrhythmia and its effect on the heart conduction system].
    Gendenshteĭn EI; Kostin IaV
    Farmakol Toksikol; 1976; 39(4):426-8. PubMed ID: 1027568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Future of antiarrhythmic drugs.
    Darbar D; Roden DM
    Curr Opin Cardiol; 2006 Jul; 21(4):361-7. PubMed ID: 16755206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New aspects of the electrophysiologic effect of antiarrhythmic agents].
    Antoni H; Weirich J
    Herz; 1990 Apr; 15(2):61-9. PubMed ID: 2188893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practical aspects in the utilization of commonly used antiarrhythmic drugs.
    Waldo AL; Storm OG
    J Med Assoc State Ala; 1974 Jun; 43(12):739-42. PubMed ID: 4847300
    [No Abstract]   [Full Text] [Related]  

  • 39. Cellular aspects of antiarrhythmic activity.
    Carmeliet E
    Verh K Acad Geneeskd Belg; 1975; 37(5-6):229-50. PubMed ID: 1220361
    [No Abstract]   [Full Text] [Related]  

  • 40. Is there a need for new antiarrhythmic drugs?
    Roden DM
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():13-8. PubMed ID: 8734158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.